Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Reduced dose post-transplant cytoxan (Intermediate -Dose) in combination with abatacept after matched unrelated donor transplant for high -risk hematological malignancy may reduce treatment related mortality and risk of relapse.

Yasser Khaled, Juan Varela, Samer Khaled, Rachel Hatton, Megan Smith, Sean Deygoo, Andrew Nguyen, Hang Le Nguyen, C. Brooke Adams

Blood (2025) 146 (Supplement 1): 4196.

https://doi.org/10.1182/blood-2025-4196

Published: 2025

Journal Articles

Abatacept in combination with post-transplant cyclophosphamide and tacrolimus may improve survival and non-relapse mortality without increasing relapse risk after allogeneic stem cell transplantation

Yasser Khaled, Samer Khaled, Juan Varela, Megan Smith, Rachel Hatton, Hang Le Nguyen, Sean Deygoo, Andrew Nguyen, C. Brooke Adams

Blood (2025) 146 (Supplement 1): 4218.

https://doi.org/10.1182/blood-2025-4218

Published: 2025